Maravai Lifesciences Holdings (MRVI) Restructuring Costs (2023 - 2026)

Maravai Lifesciences Holdings' Restructuring Costs history runs 4 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Restructuring Costs changed N/A year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $20.7 million (up 1035350.0% YoY), while the FY2025 annual figure was $17.8 million, up 1568.45% from the prior year.
• Restructuring Costs was $2.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from $10.4 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $10.4 million in Q4 2025 to a low of -$1.2 million in Q1 2024.
• Historically, Restructuring Costs has averaged $3.2 million across 4 years, with a median of $1.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Restructuring Costs plunged 99.91% in 2024, then surged 184750.0% in 2025.
• A 4-year view of Restructuring Costs shows it stood at $6.5 million in 2023, then slumped by 99.91% to $6000.0 in 2024, then jumped by 173916.67% to $10.4 million in 2025, then plunged by 72.44% to $2.9 million in 2026.
• The last three Restructuring Costs figures came in at $2.9 million (Q1 2026), $10.4 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.